Published in Vaccine on September 04, 2007
Challenges for vaccination in the elderly. Immun Ageing (2007) 1.42
Targeted vaccine selection in influenza vaccination. Dtsch Arztebl Int (2013) 1.36
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One (2009) 1.04
The effect of rosuvastatin in a murine model of influenza A infection. PLoS One (2012) 0.89
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults. Infect Chemother (2013) 0.87
Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart (2015) 0.82
Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed? Med Microbiol Immunol (2009) 0.82
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study. Hum Vaccin Immunother (2012) 0.81
Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects. Immun Ageing (2008) 0.79
Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons. Hum Vaccin Immunother (2014) 0.79
A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis. Iran J Basic Med Sci (2016) 0.75
It is time to abandon "expected bladder capacity." Systematic review and new models for children's normal maximum voided volumes. Neurourol Urodyn (2013) 2.04
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis (2011) 1.06
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract (2010) 0.93
Risk factors for invasive disease among children in Spain. J Infect (2004) 0.91
Factors associated to breastfeeding cessation before 6 months. Rev Lat Am Enfermagem (2010) 0.88
Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J (2010) 0.83
Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics (2014) 0.79
Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain. BMC Infect Dis (2015) 0.79
Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study. Hum Vaccin Immunother (2013) 0.79
Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infect Dis (2014) 0.76
Intussusception following rotavirus vaccination in the Valencia Region, Spain. Hum Vaccin Immunother (2015) 0.75
Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain. Pediatr Infect Dis J (2016) 0.75
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice. AIDS (2015) 0.75
MF59™-adjuvanted seasonal influenza vaccine in young children. Expert Rev Vaccines (2011) 0.75